Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Aleukemic mast cell leukemia with abnormal immunophenotype and c-kit mutation D816V.

Leukemia & lymphoma - 1 Nov 2004

Noack Frank, Sotlar Karl, Notter Martin, Thiel Eckhard, Valent Peter, Horny Hans-Peter

Abstract excerpt

Mastocytosis comprises a heterogeneous group of disorders characterized by proliferation and accumulation of mast cells in 1 or more organ systems. Mast cell leukemia (MCL) is an extremely rare subtype of mastocytosis in which a leukemic spread of mast cells and a rapid progression of disease is seen. In typical cases, mast cells are found in the peripheral blood. However, an aleukemic variant of MCL (formerly...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Mast Cells
Share to Antigens, Differentiation, Myelomonocytic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Bone Marrow

Share to CD2 Antigens

Share to Leukemia

Share to Mastocytosis

Share to Proto-Oncogene Proteins c-kit

Share to Receptors, Interleukin-2

Source

Identifiers

PMID: 15512820
DOI: 10.1080/10428190412331272695

Genes

KIT

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Aleukemic mast cell leukemia with abnormal immunophenotype and c-kit mutation D816V.PMID 15512820Read ↗

A case of aleukemic mast cell leukemia with an underlying myeloproliferative neoplasm: Morphological and molecular characteristics of a highly aggressive disease.Semantic proximity Read ↗

Mastocytosis: state of the art.Semantic proximity Read ↗

Recent advances in the understanding and therapeutic management of mastocytosisSemantic proximity Read ↗

Systemic mastocytosis in adults: 2013 update on diagnosis, risk stratification, and management.Semantic proximity Read ↗

Mastocytosis.Semantic proximity Read ↗

Diagnosis, progression patterns and prognostication in mastocytosis.Semantic proximity Read ↗

Mastocytosis and related disorders.Semantic proximity Read ↗

Mast Cell Leukemia: An Update with a Practical ReviewSemantic proximity Read ↗

Systemic mastocytosis in adults: 2015 update on diagnosis, risk stratification, and management.Semantic proximity Read ↗

Mast cell disease associated with acute myeloid leukemia: detection of a new c-kit mutation Asp816His.Semantic proximity Read ↗

KIT-Targeting Drugs in the Management of Nonadvanced and Advanced Systemic Mastocytosis.Semantic proximity Read ↗

Advanced systemic mastocytosis: the impact of KIT mutations in diagnosis, treatment, and progression.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.